Lutathera: payments to doctors
Payments that named Lutathera as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $30.7M
- Providers
- 7,072
- Transactions
- 19,778
- Average per transaction
- $1,553
The per-transaction average — $1,553 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,072 providers the average total is $4,344, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Advanced Accelerator Applications | $30,110,610 | 98.0% |
| Novartis | $610,167 | 2.0% |